Xgeva Injection
Pricing Report NDC 55513-730-21

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

The current wholesale acquisition cost for Xgeva (NDC 55513-730-21) is $2001.51678 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jan 07, 2026.

As a a human prescription drug provided by Amgen, Inc, this medication is distributed in a 1 VIAL, SINGLE-USE in 1 CARTON / 1.7 mL in 1 VIAL, SINGLE-USE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$2,001.51678
Per ML

Effective Date
Jan 07, 2026
Data Status
As of Jun 17, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 VIAL, SINGLE-USE in 1 CARTON / 1.7 mL in 1 VIAL, SINGLE-USE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2013, the NADAC wholesale price for (NDC ) has moved within a range of $950.36776 to $2,001.51678 per ML. Over this 12 years and 5 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$950.3678 - $2,001.5168
Market Volatility
110.60% Variance
Latest Trend
3.00%
Date Unit Price Unit Source Method Rate
Jan 07, 2026 $2001.51678 MLC/I - Chain or Independent PharmacyCode 3, 5B - Brand
Jan 07, 2026 $2001.51678 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Jan 07, 2026 $2001.51678 MLC/I - Chain or Independent PharmacyCode 3, 5B - Brand
Jan 07, 2026 $2001.51678 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Dec 24, 2025 $1943.22018 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Jan 22, 2025 $1943.22018 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jan 22, 2025 $1943.22018 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Oct 01, 2014 $1002.50588 MLC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Oct 01, 2014 $1002.50588 MLC/I - Chain or Independent PharmacyCode 3, 5B - Brand
Oct 01, 2014 $1002.50588 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Jul 25, 2014 $996.54780 MLC/I - Chain or Independent PharmacyCode 3, 5B - Brand
Jul 25, 2014 $996.54780 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Jan 24, 2014 $968.42475 MLC/I - Chain or Independent PharmacyCode 3, 5B - Brand
Jan 24, 2014 $968.42475 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Jul 26, 2013 $950.36776 MLC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Jul 26, 2013 $950.36776 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: June 17, 2026